(Q47229260)

12 January 2018

title

Self-help weight loss versus a structured commercial program after 26 weeks: a randomized controlled study (English)

1 reference

12 January 2018

author

Richard L. Atkinson

4

1 reference

12 January 2018

author name string

Heshka S

1

1 reference

12 January 2018

Greenway F

2

1 reference

12 January 2018

Anderson JW

3

1 reference

12 January 2018

Hill JO

5

1 reference

12 January 2018

Phinney SD

6

1 reference

12 January 2018

Miller-Kovach K

7

1 reference

12 January 2018

Xavier Pi-Sunyer F

8

1 reference

12 January 2018

language of work or name

English

0 references

publication date

1 September 2000

1 reference

12 January 2018

American Journal of Medicine

published in

1 reference

12 January 2018

volume

109

1 reference

12 January 2018

issue

4

1 reference

12 January 2018

page(s)

282-287

1 reference

12 January 2018

Valvular heart disease associated with fenfluramine-phentermine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900494-0

Weight control practices of U.S. adults trying to lose weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900494-0

Improved psychological well-being, quality of life, and health practices in moderately overweight women participating in a 12-week structured weight loss program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900494-0

An initial evaluation of a commercial weight loss program: short-term effects on weight, eating behavior, and mood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900494-0

Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900494-0

Intention-to-treat analysis and the goals of clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900494-0

Regional obesity and risk of cardiovascular disease; the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900494-0

Sibutramine produces dose-related weight loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900494-0

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900494-0

Long-term maintenance of weight loss: current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900494-0

Correlates of weight loss and its maintenance over two years of follow-up among middle-aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900494-0

Clinical correlates of short- and long-term weight loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900494-0

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900494-0

Position of the American Dietetic Association: vitamin and mineral supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900494-0

10.1016/S0002-9343(00)00494-0

7 January 2021

Identifiers

DOI

1 reference

12 January 2018

PubMed ID

10996578

1 reference

12 January 2018